A Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Patients With POAG or OHT
Public ClinicalTrials.gov record NCT01654484. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I/II, Randomized, Observer-masked, Placebo-and Active-controlled, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Study identification
- NCT ID
- NCT01654484
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Santen Inc.
- Industry
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Interventions
- DE-117 Drug
- 0.0015% tafluprost Drug
- DE-117 and 0.0015% tafluprost Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2012
- Primary completion
- Oct 31, 2012
- Completion
- Oct 31, 2012
- Last update posted
- Apr 17, 2018
2012
United States locations
- U.S. sites
- 10
- U.S. states
- 6
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Santen Investigational Site | Newport Beach | California | 92663 | — |
| Santen Investigational Site | Deerfield Beach | Florida | 33064 | — |
| Santen Investigational Site | Largo | Florida | 33773 | — |
| Santen Investigational Site | Morrow | Georgia | 30260 | — |
| Santen Investigational Site | Roswell | Georgia | 30076 | — |
| Santen Investigational Site | Rochester | New York | 14618 | — |
| Santen Investigational Site | Cleveland | Ohio | 44115 | — |
| Santen Investigational Site | Austin | Texas | 78731 | — |
| Santen Investigational Site | Fort Worth | Texas | 76102 | — |
| Santen Investigational Site | San Antonio | Texas | 78240 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01654484, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 17, 2018 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01654484 live on ClinicalTrials.gov.